Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > warrants

<< Previous

Bullboard Posts

Next >>

Post by DJDawgon Aug 15, 2024 9:45am

437 Views

Post# 36180312

warrants

Just a friendly reminder that in 2 weeks a massive 57.5 million chunk of warrants expire. That is equal to about 25% of the total float. That is a big lump of shares.

I feel that that change in share dilution risk has to matter in some way. Makes for an interesting question as to what Sept will look like with the trading.

<< Previous

Bullboard Posts

Next >>

These cold weather stocks are looking to heat up for winter